Internet Insomnia Intervention: Development and Feasibility
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Sleep Initiation and Maintenance Disorders
- Sponsor
- University of Virginia
- Enrollment
- 44
- Locations
- 1
- Primary Endpoint
- Sleep efficiency, total sleep time, total wake time, sleep-onset latency, wake after sleep onset, and early morning awakening
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
This study will evaluate the effectiveness of an online cognitive behavioral therapy intervention in improving sleep, mood, and cognitive functioning in people with insomnia.
Detailed Description
Insomnia is a disorder that is characterized by a perception or complaint of inadequate or poor-quality sleep. Symptoms of insomnia include difficulty falling asleep, waking frequently during the night and having difficulty returning to sleep, waking too early in the morning, and unrefreshing sleep. Insomnia may also cause problems during the day, such as tiredness, difficulty concentrating, and irritability. Cognitive behavior therapy (CBT) has been found to have significant short- and long-term benefits for people with insomnia. Access to CBT for many people, however, is limited, due to the high cost of treatment and a lack of trained professionals in some locations. Delivering CBT via the internet could help make the treatment more widely available. This study will evaluate the effectiveness of an online CBT intervention in improving sleep, mood, and cognitive functioning in people with insomnia. Participants in this open label study will be randomly assigned to receive the online CBT intervention either immediately or after a 4-month waiting period. Participants will use the online program for 1 to 2 hours per week for 8 weeks. Participants will keep track of their sleep patterns for the first and last 2 weeks of a 4-month period by keeping a daily diary and wearing a wrist watch device that monitors movement. All participants will report to the study site for baseline evaluations before beginning treatment and for final evaluations upon completing the program, about 4 months after study entry.
Investigators
Lee M Ritterband
Associate Professor
University of Virginia
Eligibility Criteria
Inclusion Criteria
- •Subjective complaints of poor sleep
- •Difficulties falling and/or staying asleep (sleep onset latency and/or wake after sleep onset is greater than 30 minutes; sleep efficiency is less than 85%)
- •Sleep difficulties at least 3 nights per week
- •Sleep difficulties have persisted for more than 6 months
- •At least one daytime problem due to poor sleep (e.g., fatigue, performance impairment, or mood disturbance)
- •Daytime problems due to sleep disturbances cause marked distress or significant impairment in social or occupational functioning
- •Has internet access
Exclusion Criteria
- •Presence of other sleep disorders (as evaluated by specific questions from structured interview) (e.g., sleep apnea, periodic leg movements while sleeping, or parasomnias)
- •Significant psychological distress (including clinical depression and anxiety), as determined using the Beck Depression Inventory (BDI), STPI, Patient Health Questionnaire (PHQ), and clinical interview
- •Substance use or medical condition that causes sleep problems
- •Currently receiving psychological treatment
- •Taking medications that have not been stabilized for the 3 months prior to study entry
- •Regularly goes to sleep after 2am or wakes after 9am
- •Shift worker
Outcomes
Primary Outcomes
Sleep efficiency, total sleep time, total wake time, sleep-onset latency, wake after sleep onset, and early morning awakening
Time Frame: Measured at baseline and Months 3 and 9
Insomnia Severity Index
Time Frame: Measured at baseline and Months 3 and 9
Beliefs and attitudes about sleep as measured by the Dysfunctional Beliefs and Attitudes about Sleep scale (DBAS 16)
Time Frame: Measured at baseline and Month 3
Sleep knowledge
Time Frame: Measured at baseline and Month 3
Fatigue as measured by the Multidimensional Fatigue Symptom Inventory (MFSI)
Time Frame: Measured at baseline and Month 3
Depression as measured by the Beck Depression Inventory 2
Time Frame: Measured at baseline and Month 3
Anxiety as measured by the State-Trait Personality Inventory (STPI)
Time Frame: Measured at baseline and Month 3
Cognitive functioning as measured by the Headminder's Customized Research Tool (CRT) and Conner's Continuous Performance Test (CPT)
Time Frame: Measured at baseline and Month 3
Secondary Outcomes
- Cost-benefit measures (direct and indirect costs associated with insomnia)(Measured at baseline and Months 3 and 9)
- Quality of life as measured by the SF-12 Health Survey(Measured at baseline and Month 3)
- Feedback regarding use of the internet intervention, including post-treatment ratings of treatment credibility, acceptability, effectiveness, satisfaction, and ease of use of the internet(Measured at Month 3)